AU2002213893A1 - Nuclear receptor l66 and methods of use - Google Patents

Nuclear receptor l66 and methods of use

Info

Publication number
AU2002213893A1
AU2002213893A1 AU2002213893A AU1389302A AU2002213893A1 AU 2002213893 A1 AU2002213893 A1 AU 2002213893A1 AU 2002213893 A AU2002213893 A AU 2002213893A AU 1389302 A AU1389302 A AU 1389302A AU 2002213893 A1 AU2002213893 A1 AU 2002213893A1
Authority
AU
Australia
Prior art keywords
methods
nuclear receptor
nuclear
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002213893A
Inventor
Georg Casari
Michael Hofer
David Jackson
Harald Kranz
Kerstin Otte
Bettina Remmel
Jorg Suckow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sygnis Pharma AG
Original Assignee
Lion Bioscience AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lion Bioscience AG filed Critical Lion Bioscience AG
Publication of AU2002213893A1 publication Critical patent/AU2002213893A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70567—Nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2002213893A 2000-09-16 2001-09-07 Nuclear receptor l66 and methods of use Abandoned AU2002213893A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP00120370 2000-09-16
EP00120370.2 2000-09-16
EP01111658.9 2001-05-14
EP01111658 2001-05-14
PCT/EP2001/010323 WO2002022817A2 (en) 2000-09-16 2001-09-07 Nuclear receptor l66 and methods of use

Publications (1)

Publication Number Publication Date
AU2002213893A1 true AU2002213893A1 (en) 2002-03-26

Family

ID=26071406

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002213893A Abandoned AU2002213893A1 (en) 2000-09-16 2001-09-07 Nuclear receptor l66 and methods of use

Country Status (4)

Country Link
EP (1) EP1317542A2 (en)
AU (1) AU2002213893A1 (en)
CA (1) CA2420932A1 (en)
WO (1) WO2002022817A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030109467A1 (en) * 2001-11-15 2003-06-12 Isis Pharmaceuticals Inc. Antisense modulation of human FXR expression
AU2003219028A1 (en) * 2002-04-13 2003-10-27 Lion Bioscience Ag NON-PRIMATE FXRb AS A LANOSTEROL SENSING NUCLEAR HORMONE RECEPTOR AND RELATED USES

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5932699A (en) * 1995-01-13 1999-08-03 The General Hospital Corporation Retinoid X receptor-interacting polypeptides
US6005086A (en) * 1995-01-13 1999-12-21 The Salk Institute For Biological Studies Farnesoid activated receptor polypeptides, and nucleic acid encoding the same
US5728548A (en) * 1995-06-29 1998-03-17 Genetics Institute, Inc. Retinoid receptor-1 (RR1) and DNA encoding RR1
AU780658B2 (en) * 1999-03-26 2005-04-07 City Of Hope Method of affecting cholesterol catabolism using nuclear bile acid receptor

Also Published As

Publication number Publication date
CA2420932A1 (en) 2002-03-21
WO2002022817A2 (en) 2002-03-21
EP1317542A2 (en) 2003-06-11
WO2002022817A3 (en) 2003-03-27

Similar Documents

Publication Publication Date Title
AU2001253126A1 (en) (+) naloxone and epinephrine combination therapy
AU7524601A (en) T cell receptor fusions and conjugates and methods of use thereof
HUP0200429A2 (en) Soluble receptor br43x2 and methods of using
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
EP1183030A4 (en) Methods of making and using n-desmethylzopiclone
AU2002211183A1 (en) Prosthetic construct and methods for its manufacture and use
AU2002213346A1 (en) Osteopontin-coated surfaces and methods of use
AU2001288972A1 (en) Antipsychotic sulfonamide-heterocycles, and methods of use thereof
AU1334602A (en) Osteopontin-coated surfaces and methods of use
AU8235601A (en) Dispenser and method of use
AU2001236684A1 (en) System and method for user interface translation
AU2001292710A1 (en) Well packer and method
AU3128102A (en) Surface transfection and expression procedure
AU2001249567A1 (en) Shaped springs and methods of fabricating and using shaped springs
AU2002310237A1 (en) Sponge-derived terpenoids and methods of use
AU2001261375A1 (en) Human caspase-12 materials and methods
GB0020363D0 (en) Detector asssemblies and methods
AU2001236965A1 (en) Method and system of user profile generation
AU2001261496A1 (en) Luxo-sigma54 interactions and methods of use
EP1263935A4 (en) Scytonemin and methods of using thereof
AU2002213893A1 (en) Nuclear receptor l66 and methods of use
AU3398200A (en) Pomegranate extracts and methods of using thereof
GB0028589D0 (en) Optical devices and methods
AU2002256556A1 (en) Sea-trosy and related methods
GB0114047D0 (en) Methods and assemblies